Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome (Q42734774)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 October 2005
edit
Language Label Description Also known as
English
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
scientific article published on 28 October 2005

    Statements

    Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome (English)
    1 reference
    G Bougeard
    1 reference
    S Baert-Desurmont
    1 reference
    I Tournier
    1 reference
    S Vasseur
    1 reference
    C Martin
    1 reference
    L Brugieres
    1 reference
    A Chompret
    1 reference
    B Bressac-de Paillerets
    1 reference
    C Bonaiti-Pellie
    1 reference
    T Frebourg
    1 reference
    28 October 2005
    1 reference
    43
    1 reference
    531-533
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit